Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls
Open Access
- 1 December 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Adolescent Health
- Vol. 35 (6), 434-441
- https://doi.org/10.1016/j.jadohealth.2004.07.005
Abstract
To conduct a longitudinal comparison of bone mineral density (BMD) in 370 adolescent girls, aged 12-18, who self-selected depot medroxyprogesterone acetate (DMPA) or an oral contraceptive (OC) containing 20 microg ethinyl estradiol/100 microg levonorgestrel with that in girls who received no hormonal treatment (control group). Lumbar spine and femoral neck BMD measurements were obtained by dual energy x-ray absorptiometry at baseline and 12 months. Data were analyzed with repeated measures analysis of covariance methods. Over 12 months, lumbar spine BMD decreased in the DMPA group (n = 29), with a mean percent change of -1.4% (95% confidence interval [CI] -2.73, -0.10), and increased by a mean of 3.8% (95% CI 3.11, 4.57) in the control group [n = 107 (p < .001)]. The increase in mean percent change in lumbar spine BMD in the OC group (n = 79), 2.3% (95% CI 1.49, 3.18), was significantly smaller than in the control group (p = .03). Over 12 months, the mean percent change in femoral neck BMD was -2.2% (95% CI -3.95, -0.39) in the DMPA group, but increased 2.3% (95% CI 1.29, 3.27) in the control group (p < .001). The increase in mean percent change at the femoral neck in the OC group, 0.3% (95% CI -0.87, 1.41), was significantly lower than in the control group (p = .03). Our study contributes to an increasing body of knowledge indicating a negative impact of DMPA on bone health in young women. Additional findings suggest a potential adverse effect of an OC containing 20 microg ethinyl estradiol/100 microg levonorgestrel on bone health in adolescents.Keywords
This publication has 22 references indexed in Scilit:
- Bone mineral density in adolescent females using depot medroxyprogesterone acetateJournal of Pediatric and Adolescent Gynecology, 2004
- The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent womenContraception, 2004
- Injectable Hormone Contraception and Bone Density: Results from a Prospective StudyEpidemiology, 2002
- A prospective, controlled study of the effects of hormonal contraception on bone mineral densityObstetrics & Gynecology, 2001
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Bone mass and long-term monophasic oral contraceptive treatment in young womenContraception, 1995
- A dietary calcium rapid assessment method (RAM)Topics in Clinical Nutrition, 1994
- Recovery of bone density in women who stop using medroxyprogesterone acetateBMJ, 1994
- Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: A prospective studyContraception, 1993
- Bone gain in young adult womenPublished by American Medical Association (AMA) ,1992